The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.

Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); ...

"Don't kill it, don't squish it, don't cut it up," Texas Agriculture Commissioner Sid Miller warned residents via NBC as a ...

Peak Energy, a U.S.-based company developing low-cost, giga-scale energy storage technology for the grid, announced a multi-year phased agreement in which Peak Energy will supply up to 4.75 GWh of its ...

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Cosmic Mysteries Science Can't Explain: 25 Unsolved Mysteries That Haunt Modern Science: Chemistry is more than just wearing ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...

Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated ATLANTA, GEORGIA / ACCESS Newswire / November 11, 2025 / Dogwo ...

Ambient Escapes. I have recently discovered YouTube channels like Forest Jazz Lounge and Tranquil Morning Ambience that ...

It may be tempting to channel your inner Disney princess and befriend every animal you come across. But wildlife is always better left alone.

Washington: The US on Wednesday announced sanctions against 32 entities and individuals from several countries, including India and China for links to Iran’s ballistic missile programme. The US state ...